Comac Medical Group
is now Clarenta

A new name for nearly three decades of clinical development experience.

Read the Full Announcement

Key Figures

Years of clinical experience

300+

Early-phase studies

200+

Oncology studies

Countries covered

Comac Medical Group rebrands as Clarenta

On 9 September 2026, Comac Medical Group became Clarenta, marking a new chapter in our evolution as a European clinical development partner.

The new identity reflects how our organisation has grown, from the clinical research foundations established by Comac Medical in 1997 to a more integrated partner connecting development strategy, regulatory expertise, early-phase research and clinical delivery.

Inspired by clarity, Clarenta expresses the role we play for our clients: providing clear guidance, transparent communication, and experienced support through complex clinical development. While our name has changed, the expertise, trusted relationships and commitment behind our work remain.

Read the Full Announcement

ILife Consulting’s expertise continues within Clarenta

ILife Consulting became part of Comac Medical Group in 2025, adding complementary strategic consulting and early-phase development expertise to the Group’s capabilities.

Following the rebrand of Comac Medical Group, ILife Consulting’s expertise continues within Clarenta. Clients work with the same teams and specialist knowledge, now connected to Clarenta’s broader clinical development support.

Connected expertise across clinical development

From the decisions that shape a programme to the clinical delivery that moves it forward, our expertise stays connected at every stage.

Drug development consulting

Build a clear path to clinical readiness through connected drug development consulting, CMC and regulatory expertise tailored to your programme.

LEARN MORE

Early phase development

Advance early development with experienced support for first-in-human, proof-of-concept, oncology, PK and clinical pharmacology studies across Europe.

LEARN MORE

Clinical services

Turn strategy into reliable delivery through clinical research consulting, full-service CRO capabilities and our dedicated Phase I Unit.

LEARN MORE

Clinical excellence

Explore our therapeutic expertise, clinical case studies and client testimonials to see how experience and trusted partnerships shape every programme.

LEARN MORE

Why Clarenta?
Bringing clarity to clinical complexity

Clarity before action

We anticipate risks, illuminate the decisions that matter and define a clear path forward before complexity becomes delay.

Never a black box

Senior specialists stay accessible, communication stays direct and you always understand what is happening, why it matters and what comes next.

One team holds the thread

From early development strategy through clinical execution, one connected team carries your knowledge, priorities and decisions forward.

European reach, local expertise

Direct operational presence across 24 countries combines broad European coverage with the local insight needed for stronger feasibility and delivery decisions.

Depth where complexity demands it

Our experience in early phase development, oncology and rare diseases helps us navigate trials where scientific and operational judgement matter most.

The right scale for
your study

You gain full-service CRO capabilities with the flexibility, senior attention and cost-conscious delivery your programme deserves.

Therapeutic areas

Our teams bring deep therapeutic understanding to clinical programmes across oncology and onco-haematology, rare diseases, neurology and psychiatry, respiratory diseases, dermatology and gastroenterology.

Explore Our Therapeutic Expertise